mRNA characterisation and analysis is a critical requirement to assess drug product or drug substance quality and efficacy. The complex approach to manufacturing mRNA as well as the intracellular delivery method can bring impurity risks that impact the efficacy and safety of the drug. This presentation discusses analytical approaches to characterise mRNA in early-stage development to support effective therapeutic programs including specification tests for batch release and stability study testing of mRNA drug substances and drug products.

Please complete the form to watch our webinar now: